로딩 중…
지수 로딩 중…
Emergent BioSolutions Inc.
EBS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.97-2.03%
2026-06-18
Price Chart
Emergent BioSolutions Inc.+26.39%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $411M |
| Revenue | $677M |
| Net Income | $-9M |
| Total Assets | $1.32B |
| Net Assets | $523M |
| Value | |
| P/B | 0.79x |
| P/S | 0.61x |
| EV/EBITDA | 4.95x |
| FCF Yield | 32.91% |
| Profitability | |
| ROE | -1.64% |
| ROA | -0.65% |
| Op. Margin | 10.52% |
| Revenue Growth | -29.75% |
| Earnings Growth | -90.00% |
| Financial Health | |
| Debt Ratio | 152.42% |
| Total Debt | $574M |
| FCF | $135M |
| Cash | $160M |
| Current Ratio | 4.29x |
| Net Debt/EBITDA | 2.48x |
| Performance | |
| 1Y Return | 26.39% |
| 1M Return | -1.05% |
| From 52W High | -43.28% |
| 1Y MDD | -44.24% |
| Trading | |
| Volume | 734,992 shares |
| Trading Value | $6M |
| Per Share | |
| EPS | $0.98 |
| BPS | $9.77 |